CClinicalTrials.gg
CompletedNCT06930898Updated Apr 18, 2025

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

An interventional study of Gamified Mammoverse Platform and Standard Mammoverse Platform in Health Education and Breast Neoplasms, sponsored by University of Malaya. Completed at 2 sites in 2 countries. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by University of Malaya · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Dec 2024, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Read the detailed description

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

02

Conditions studied

  • Health Education
  • Breast Neoplasms

Browse trials for

Keywords

  • Gamification
  • Health Education
  • Breast Cancer Awareness
  • Metaverse
  • Women's Health
  • Digital Health Literacy
03

In context

Breast Neoplasms

12,547 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 72 is close to the median of 72 across 9,305 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Malaya is the lead sponsor of 280 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female participants aged 18 years and above
  • Able to read and understand Chinese
  • Access to a digital device and stable internet connection
  • Willing to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment or mental health condition that affects participation
  • Inability to complete the full intervention and follow-up sessions
  • Incomplete baseline assessment
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Gamified Metaverse Education

    Participants in this group used the Mammoverse platform with gamified features, including story-based missions, interactive tasks, point-based rewards, achievement badges, and virtual incentives. The educational content was delivered through immersive scenarios to enhance engagement and motivation in learning about breast health.

    Behavioral: Gamified Mammoverse Platform

  • Active comparator
    Non-Gamified Metaverse Education

    Participants in this group accessed the Mammoverse platform without any gamified features. The virtual environment delivered identical breast health educational content, but without tasks, points, rewards, badges, or narrative elements.

    Behavioral: Standard Mammoverse Platform

Interventions

  • BehavioralGamified Mammoverse Platform

    A gamified, metaverse-based platform delivering breast health education through story-based tasks, interactive challenges, points, rewards, badges, and virtual incentives.

  • BehavioralStandard Mammoverse Platform

    A non-gamified version of the Mammoverse platform that provides the same breast health educational content.

06

What researchers measure

Primary outcomes

  1. Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention

    Assessed using an 18-item adapted Breast Health Literacy Questionnaire. Scores range from 0 to 18, with higher scores indicating greater knowledge. Main comparison is between baseline and 4-week follow-up.

    Time frame: Baseline and 4 weeks post-intervention

Secondary outcomes

  1. Change in Breast Health Knowledge Score from Baseline to Immediately Post-Intervention

    Same questionnaire used to assess immediate knowledge gain after the intervention.

    Time frame: Baseline and immediately post-intervention

Other outcomes

  1. Knowledge Retention from Immediately Post-Intervention to 4 Weeks Post

    Change in knowledge scores to evaluate retention over 4 weeks.

    Time frame: Immediately post-intervention and 4 weeks post-intervention

07

Study locations

2 sites
  • Online Recruitment - Hangzhou, Zhejiang, China
    Hangzhou, Zhejiang 31000, China
  • University of Malaya
    Kuala Lumpur, Malaysia
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06930898
Lead sponsor
University of Malaya
Responsible party
Sponsor
First posted
Apr 16, 2025
Start date
Dec 1, 2024
Primary completion
Feb 1, 2025
Completion
Mar 24, 2025
Last update
Apr 18, 2025

Study contacts

Rui Li, PhD(c)
principal investigator · University of Malaya

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion